Skip to main content

and
  1. No Access

    Article

    Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm

    Cutaneous adverse events induced by epidermal growth factor receptor (EGFR) inhibitors can hamper the patients' quality of life. The aim of our work was to draft an algorithm for the optimised management of th...

    Z. Reguiai, J. B. Bachet, C. Bachmeyer, L. Peuvrel in Supportive Care in Cancer (2012)

  2. No Access

    Article

    Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors

    Advances in the understanding of the mechanisms involved in oncogenesis have led to the development of so-called targeted therapies such as epidermal growth factor receptor (EGFR) inhibitors, which take on an ...

    L. Peuvrel, C. Bachmeyer, Z. Reguiai, J. B. Bachet, T. André in Supportive Care in Cancer (2012)